Christophe Lurquin

11.0k total citations · 4 hit papers
45 papers, 8.9k citations indexed

About

Christophe Lurquin is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Christophe Lurquin has authored 45 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Immunology, 30 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Christophe Lurquin's work include Immunotherapy and Immune Responses (41 papers), vaccines and immunoinformatics approaches (17 papers) and T-cell and B-cell Immunology (17 papers). Christophe Lurquin is often cited by papers focused on Immunotherapy and Immune Responses (41 papers), vaccines and immunoinformatics approaches (17 papers) and T-cell and B-cell Immunology (17 papers). Christophe Lurquin collaborates with scholars based in Belgium, Switzerland and France. Christophe Lurquin's co-authors include Thierry Boon, Etienne De Plaen, Catia Traversari, Pierre van der Bruggen, Patrick Chomez, Alexander Knuth, Benoı̂t Van den Eynde, Charles De Smet, Bernard Lethé and Aline Van Pel and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Christophe Lurquin

45 papers receiving 8.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1991 2.8k citations Pierre van der Bruggen, Catia Traversari et al. Science profile →
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

1994 767 citations Pierre G. Coulie, Vincent Brichard et al. profile →
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.

1992 547 citations Catia Traversari, Pierre van der Bruggen et al. profile →
Structure, chromosomal localization, and expression of 12 genes of the MAGE family

1994 513 citations Etienne De Plaen, Catia Traversari et al. Immunogenetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christophe Lurquin Belgium	32	7.3k	4.7k	3.3k	785	764	45	8.9k
Aline Van Pel Belgium	42	6.9k 0.9×	3.3k 0.7×	2.7k 0.8×	720 0.9×	905 1.2×	79	8.0k
Maria R. Parkhurst United States	37	7.1k 1.0×	3.1k 0.7×	6.0k 1.8×	1.1k 1.4×	772 1.0×	64	9.2k
Bernard Lethé Belgium	28	5.0k 0.7×	3.1k 0.6×	2.1k 0.7×	466 0.6×	465 0.6×	39	6.0k
Patrick Chomez Belgium	20	4.6k 0.6×	2.9k 0.6×	1.9k 0.6×	526 0.7×	527 0.7×	26	5.8k
Thomas Wölfel Germany	32	5.1k 0.7×	2.8k 0.6×	2.8k 0.9×	438 0.6×	612 0.8×	70	6.4k
Mona El‐Gamil United States	29	4.4k 0.6×	2.8k 0.6×	4.0k 1.2×	938 1.2×	481 0.6×	41	6.6k
Hyam I. Levitsky United States	39	6.7k 0.9×	1.9k 0.4×	3.7k 1.1×	902 1.1×	392 0.5×	65	8.3k
Karine Breckpot Belgium	54	4.5k 0.6×	3.4k 0.7×	3.2k 1.0×	1.1k 1.4×	1.0k 1.3×	170	7.6k
Ada M. Kruisbeek Netherlands	49	5.4k 0.7×	2.0k 0.4×	1.8k 0.6×	684 0.9×	906 1.2×	122	7.3k
Timothy M. Clay United States	41	3.2k 0.4×	2.6k 0.6×	2.2k 0.7×	796 1.0×	491 0.6×	97	5.9k

Countries citing papers authored by Christophe Lurquin

Since Specialization

Citations

This map shows the geographic impact of Christophe Lurquin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Lurquin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Lurquin more than expected).

Fields of papers citing papers by Christophe Lurquin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Lurquin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Lurquin. The network helps show where Christophe Lurquin may publish in the future.

Co-authorship network of co-authors of Christophe Lurquin

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Lurquin. A scholar is included among the top collaborators of Christophe Lurquin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Lurquin. Christophe Lurquin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Jingjing, Stefania Canè, Didier Colau, et al.. (2017). Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes. Nature Communications. 8(1). 1404–1404. 178 indexed citations

Corbière, Véronique, Jacques Chapiro, Vincent Stroobant, et al.. (2011). Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases. Cancer Research. 71(4). 1253–1262. 142 indexed citations

Demotte, Nathalie, Grégoire Wieërs, Patrick Van Deŕ Smissen, et al.. (2010). A Galectin-3 Ligand Corrects the Impaired Function of Human CD4 and CD8 Tumor-Infiltrating Lymphocytes and Favors Tumor Rejection in Mice. Cancer Research. 70(19). 7476–7488. 132 indexed citations

Bruggen, Pierre van der, Catia Traversari, Patrick Chomez, et al.. (2007). A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.. PubMed. 178(5). 2617–21. 87 indexed citations

Karanikas, Vaios, Christophe Lurquin, Didier Colau, et al.. (2003). Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus. The Journal of Immunology. 171(9). 4898–4904. 88 indexed citations

Bilsborough, Janine, Christophe Panichelli, Guy Warnier, et al.. (2002). A MAGE‐3 peptide presented by HLA‐B44 is also recognized by cytolytic T lymphocytes on HLA‐B18. Tissue Antigens. 60(1). 16–24. 11 indexed citations

Coulie, Pierre G., Vaios Karanikas, Christophe Lurquin, et al.. (2002). Cytolytic T‐cell responses of cancer patients vaccinated with a MAGE antigen. Immunological Reviews. 188(1). 33–42. 101 indexed citations

Smet, Charles De, et al.. (1999). DNA Methylation Is the Primary Silencing Mechanism for a Set of Germ Line- and Tumor-Specific Genes with a CpG-Rich Promoter. Molecular and Cellular Biology. 19(11). 7327–7335. 499 indexed citations

Serrano, Alfonso, Christophe Lurquin, Etienne De Plaen, et al.. (1999). Quantitative evaluation of the expression ofMAGE genes in tumors by limiting dilution of cDNA libraries. International Journal of Cancer. 83(5). 664–669. 28 indexed citations

10.

Bour, H, et al.. (1998). Differential Requirement for CD4 Help in the Development of an Antigen-Specific CD8+ T Cell Response Depending on the Route of Immunization. The Journal of Immunology. 160(11). 5522–5529. 32 indexed citations

11.

Smet, Charles De, Christophe Lurquin, Etienne De Plaen, et al.. (1997). Genes coding for melanoma antigens recognised by cytolytic T lymphocytes. Eye. 11(2). 243–248. 17 indexed citations

12.

Lurquin, Christophe, Charles De Smet, Francis Brasseur, et al.. (1997). Two Members of the HumanMAGEBGene Family Located in Xp21.3 Are Expressed in Tumors of Various Histological Origins. Genomics. 46(3). 397–408. 128 indexed citations

13.

Plaen, Etienne De, Christophe Lurquin, Bernard Lethé, et al.. (1997). Identification of Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes. Methods. 12(2). 125–142. 51 indexed citations

14.

Warnier, Guy, Catherine Uyttenhove, Thomas F. Gajewski, et al.. (1996). Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A. International Journal of Cancer. 67(2). 303–310. 47 indexed citations

15.

Kermouni, Abdenaim, Karen C. Arden, Joris Vermeesch, et al.. (1995). The IL-9 Receptor Gene (IL9R): Genomic Structure, Chromosomal Localization in the Pseudoautosomal Region of the Long Arm of the Sex Chromosomes, and Identification of IL9R Pseudogenes at 9qter, 10pter, 16pter, and 18pter. Genomics. 29(2). 371–382. 62 indexed citations

16.

Smet, Charles De, Stéphane Courtois, Isabella Faraoni, et al.. (1995). Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene. Immunogenetics. 42(4). 282–290. 84 indexed citations

17.

Plaen, Etienne De, Catia Traversari, José J. Gaforio, et al.. (1994). Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics. 40(5). 360–369. 513 indexed citations breakdown →

18.

Boon, Thierry, B. Van den Eynde, Heather A. Hirsch, et al.. (1994). Genes Coding for Tumor-specific Rejection Antigens. Cold Spring Harbor Symposia on Quantitative Biology. 59(0). 617–622. 12 indexed citations

19.

Bruggen, Pierre van der, Catia Traversari, Patrick Chomez, et al.. (1991). A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma. Science. 254(5038). 1643–1647. 2784 indexed citations breakdown →

20.

Wölfel, Thomas, Aline Van Pel, Etienne De Plaen, et al.. (1987). Immunogenic (tum−) variants obtained by mutagenesis of mouse mastocytoma P815. Immunogenetics. 26(3). 178–187. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact